Cargando…

Cognitive Dysfunction Contributes to Mobility Impairments in Huntington’s Disease

BACKGROUND: Huntington’s disease (HD) is a progressive neurodegenerative disorder that results in a gradual decline in mobility and balance. Increasing evidence has documented an important role of executive function in the safe ambulation of the elderly and people with a variety of neurological diso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kloos, Anne D., Kegelmeyer, Deb A., Fritz, Nora E., Daley, Allison M., Young, Gregory S., Kostyk, Sandra K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757646/ https://www.ncbi.nlm.nih.gov/pubmed/29254103 http://dx.doi.org/10.3233/JHD-170279

Ejemplares similares

The Impact of Different Types of Assistive Devices on Gait Measures and Safety in Huntington's Disease
por: Kloos, Anne D., et al.
Publicado: (2012)

Clinical recommendations to guide physical therapy practice for Huntington disease
por: Quinn, Lori, et al.
Publicado: (2020)

Clinical Decision Trees to Guide Physical Therapy Management of Persons with Huntington’s Disease
por: Fritz, Nora E., et al.
Publicado: (2022)

Physical Therapy and Exercise Interventions in Huntington’s Disease: A Mixed Methods Systematic Review
por: Fritz, Nora E., et al.
Publicado: (2017)

The Step Test Evaluation of Performance on Stairs (STEPS): Validation and reliability in a neurological disorder
por: Kloos, Anne D., et al.
Publicado: (2019)

Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS
por: Edwards, Erin M., et al.
Publicado: (2020)

Mild Cognitive Impairment as an Early Landmark in Huntington's Disease
por: Zhang, Ying, et al.
Publicado: (2021)

Measuring the functional impact of cognitive impairment in Huntington’s disease
por: Horta-Barba, Andrea, et al.
Publicado: (2022)

Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington’s disease
por: Hwang, Sunhee, et al.
Publicado: (2015)

A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease
por: Vinther-Jensen, Tua, et al.
Publicado: (2014)

Synaptic RTP801 contributes to motor-learning dysfunction in Huntington’s disease
por: Martín-Flores, Núria, et al.
Publicado: (2020)

Olfactory Dysfunction in Huntington’s Disease
por: Patino, Jorge, et al.
Publicado: (2021)

Do Disruptions in the Circadian Timing System Contribute to Autonomic Dysfunction in Huntington’s Disease?
por: Park, Saemi, et al.
Publicado: (2019)

Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments
por: Horta-Barba, Andrea, et al.
Publicado: (2023)

Do Changes in Synaptic Autophagy Underlie the Cognitive Impairments in Huntington’s Disease?
por: Grosso Jasutkar, Hilary, et al.
Publicado: (2021)

Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease
por: Murueta-Goyena, Ane, et al.
Publicado: (2023)

Neuron type‐specific increase in lamin B1 contributes to nuclear dysfunction in Huntington’s disease
por: Alcalá‐Vida, Rafael, et al.
Publicado: (2020)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease
por: Claassen, Daniel O., et al.
Publicado: (2020)

RTP801/REDD1 Is Involved in Neuroinflammation and Modulates Cognitive Dysfunction in Huntington’s Disease
por: Pérez-Sisqués, Leticia, et al.
Publicado: (2021)

Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease
por: Wilton, Daniel K., et al.
Publicado: (2023)

Impaired Cerebrovascular Reactivity in Huntington’s Disease
por: Chan, Suk Tak, et al.
Publicado: (2021)

Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington’s disease
por: Crevier-Sorbo, Gabriel, et al.
Publicado: (2020)

Cognitive Reserve in Early Manifest Huntington Disease Patients: Leisure Time Is Associated with Lower Cognitive and Functional Impairment
por: Migliore, Simone, et al.
Publicado: (2022)

Multiple pathways contribute to the pathogenesis of Huntington disease
por: Li, Shihua, et al.
Publicado: (2006)

Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington’s Disease
por: Serranilla, Melissa, et al.
Publicado: (2022)

Emotion recognition and experience in Huntington's disease: Is there a differential impairment?
por: Ille, Rottraut, et al.
Publicado: (2011)

Automated Assessment of Movement Impairment in Huntington’s Disease
Publicado: (2018)

Theory of Mind Is Impaired in Mild to Moderate Huntington’s Disease Independently from Global Cognitive Functioning
por: Lagravinese, Giovanna, et al.
Publicado: (2017)

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
por: Harris, Kate L, et al.
Publicado: (2020)

Varenicline improves motor and cognitive symptoms in early Huntington’s disease
por: McGregor, Ailsa L, et al.
Publicado: (2016)

DNA Methylation in Huntington’s Disease
por: Zsindely, Nóra, et al.
Publicado: (2021)

Author Correction: Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease
por: Wilton, Daniel K., et al.
Publicado: (2023)

Objective Acoustic Quantification of Phonatory Dysfunction in Huntington's Disease
por: Rusz, Jan, et al.
Publicado: (2013)

Cardiac Dysfunction in the BACHD Mouse Model of Huntington’s Disease
por: Schroeder, Analyne M., et al.
Publicado: (2016)

Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease
por: Rusz, Jan, et al.
Publicado: (2014)

Striatal Network Models of Huntington's Disease Dysfunction Phenotypes
por: Zheng, Pengsheng, et al.
Publicado: (2017)

Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice
por: Tong, Xiaoping, et al.
Publicado: (2014)

An altered extracellular matrix–integrin interface contributes to Huntington’s disease-associated CNS dysfunction in glial and vascular cells
por: Hernandez, Sarah J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kv4qi0u3d8ubo26aohfu5chj4u